Effects of GLP-1 receptor agonists on the degree of liver fibrosis and CRP in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: A systematic review and meta-analysis.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Effects of GLP-1 receptor agonists on the degree of liver fibrosis and CRP in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: A systematic review and meta-analysis.
- Published In:
- Primary care diabetes, 18(3), 268-276 (2024)
- Authors:
- Fang, Lixuan, Li, Jine, Zeng, Haixia, Liu, Jianping
- Database ID:
- RPEP-08178
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-08178APA
Fang, Lixuan; Li, Jine; Zeng, Haixia; Liu, Jianping. (2024). Effects of GLP-1 receptor agonists on the degree of liver fibrosis and CRP in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: A systematic review and meta-analysis.. Primary care diabetes, 18(3), 268-276. https://doi.org/10.1016/j.pcd.2024.03.005
MLA
Fang, Lixuan, et al. "Effects of GLP-1 receptor agonists on the degree of liver fibrosis and CRP in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: A systematic review and meta-analysis.." Primary care diabetes, 2024. https://doi.org/10.1016/j.pcd.2024.03.005
RethinkPeptides
RethinkPeptides Research Database. "Effects of GLP-1 receptor agonists on the degree of liver fi..." RPEP-08178. Retrieved from https://rethinkpeptides.com/research/fang-2024-effects-of-glp1-receptor
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.